סך הכנסות החברה Heron Therapeutics, Inc. (HRTX)

סמל תאגידי ולוגו של Heron Therapeutics Inc (HRTX)

How can pain and oncology therapies be integrated into hospital protocols? Actual sales for Heron Therapeutics demonstrate current dynamics, where 0.15 reflects the latest metric value. The solution lies in surgeons' trust in Heron Therapeutics innovations that reduce opioid load. The business's stability is ensured by proprietary Zynrelef polymer systems, which protect profitability from generic expansion in the supportive therapy segment.

HRTX - הכנסות החברה Heron בטווח 04.07.2022 - 18.11.2026

פילוחים אנליטיים של חברת Heron (HRTX)

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח כללי של החברה:Heron Therapeutics Inc - HRTX
מוצר סדרתי של Heron Therapeutics, Inc.

This indicator captures daily cash inflows from product sales, excluding quarterly distortions to assess real demand. Rising values confirm the business's liquidity, though caution is required to avoid overpaying for the asset. By analyzing the company's aggregate sales figures, an investor can track the dynamics of commercial expansion. For Heron Therapeutics (HRTX), this reflects market recognition of its innovative analgesics. Stable revenue confirms surgeons' confidence in drugs that reduce opioid dependence.